Evidence map›Paper›PMID 40474880›Full record

ArticleJournal of patient experience2025

Exploring Patients' Motivations in Using Platelet-Rich Plasma as Their Primary Care Therapy for Managing Knee Osteoarthritis: A Focus Group Discussion.

Maria Ruth Pineda-Cortel, Jan Tyrone Cabrera, Adrian Villavieja, Mary Monica Bernardo-Bueno, Minerva Daya, John Emil Alegre, Renz Cleve Vergara, Rinnel Brenan Bonifacio, Consuelo G Suarez

Abstract read
In one paragraph

Article in Journal of patient experience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria Ruth Pineda-CortelDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.ORCID https://orcid.org/0000-0001-6157-7012
Jan Tyrone CabreraFaculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Adrian VillaviejaGraduate School, University of Santo Tomas, Manila, Philippines.
Mary Monica Bernardo-BuenoFaculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Minerva DayaResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.
John Emil AlegreUniversity of Santo Tomas Hospital, Manila, Philippines.
Renz Cleve VergaraResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.
Rinnel Brenan BonifacioResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.
Consuelo G SuarezFaculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knee osteoarthritis (KOA) is a degenerative disease that causes pain and burden in patients. Aside from surgery, clinicians tout the potential use of platelet-rich plasma. This study explores motivation in terms of perceptions, experiences, and recommendations of KOA patients who received platelet-rich plasma (PRP) as primary care therapy. A qualitative approach via focus group discussion was conducted. Data were analyzed using thematic analysis and visualized using MAXQDA. Patients' motivation for the use of PRP was based on three factors: (1) their perception of PRP as a therapy, (2) their lived experiences post-PRP therapy, and (3) their willingness to recommend PRP to others as a primary care therapy. The elements of each theme were identified and ranked based on how often the patients expressed the same thought, with willingness (f=5), alternative therapy (f=7), and pain (f=27) ranking highest. Physicians' recommendations, preference for a non-surgical approach, and later on, reduced pain and improved quality of life made them believe in the effectiveness of PRP as primary care therapy to alleviate KOA symptoms.

Indexed as

biologic therapychronic pain managementknee osteoarthritisplatelet-rich plasmaprimary care

Identifiers

PMID40474880
PMCPMC12138209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.